L Lisata Therapeutics
L
Închisă
3.15 -2.17
Rezumat
Modificarea prețului
24h
Minim
3.15
Maxim
3.16
Venit | 1.3M -3M |
|---|---|
Vânzări | 100K 100K |
Marjă de profit | -2,954 |
Angajați | 21 |
Următoarele câștiguri | 14 mai 2026 |
|---|
Capitalizare de piață | -16M 23M |
|---|---|
Deschiderea anterioară | 5.32 |
Închiderea anterioară | 3.15 |
Lisata Therapeutics Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Știri relevante
Comparație
Modificare preț
Lisata Therapeutics Așteptări
Date financiare
Cheltuieli de vânzare și administrare
Profit pre-impozitare
Vânzări
Profit operațional
$
Despre Lisata Therapeutics
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.